Personalized Medicine in lung Cancer

The era of personalized treatment for lung cancer will involve a comprehensive genomic characterization of adenocarcinoma, squamous-cell carcinoma, and small-cell carcinoma into various subtypes. Precision medicine is to develop treatments that exploit weak spots in tumor cells to destroy only the cancer cells (as compared to traditional chemotherapy and radiation). Weak spots have been found in two genes, EGFR and ALK, both found in adenocarcinoma NSCLC.

  • Lung cancer surgery
  • Management of Chemotherpay
  • Non-smallcell lung cancer
  • Pathogenesis
  • Lung cancer clinical trials and research

Related Conference of Personalized Medicine in lung Cancer

August 02-03, 2017

13th European Pathology Congress

Milan, Italy
August 23-24 , 2017

International Conference on Microbial Pathogenesis,Infectious Diseases & Control

Toronto, Canada
Avail Upto 21 ACCME Credits
August 23-24, 2017

4th World Congress on Breast Pathology and Cancer Diagnosis

Toronto, Canada [Holiday Inn Toronto International Airport]
November 13-14, 2017

14th Asia Pacific Pathology Congress

Osaka, Japan
November 15-16, 2017

2nd International Conference on Digital Pathology

San Antonio, USA
April 23-24, 2018

14th International Conference on Pathology

Orlando, USA
August 27-28, 2018

4th International Conference on Cytopathology & Histopathology

Boston | Massachusetts | USA

Personalized Medicine in lung Cancer Conference Speakers

Recommended Sessions

Related Journals

Are you interested in